# Treatment of Latent TB Infection for Jailed Persons

> **NCT00128206** · PHASE3 · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 364 (actual)

## Conditions studied

- Tuberculosis

## Interventions

- **DRUG:** Isoniazid
- **DRUG:** Rifampin

## Key facts

- **NCT ID:** NCT00128206
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-11
- **Primary completion:** 2008-10
- **Final completion:** 2009-09
- **Target enrollment:** 364 (ACTUAL)
- **Last updated:** 2020-07-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00128206

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00128206, "Treatment of Latent TB Infection for Jailed Persons". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00128206. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*